InnoDiab delivers structured clinical trial execution in diabetes, obesity and related cardiometabolic indications

Since 2016, we have been supporting pharmaceutical sponsors and contract research organisations (CROs) with the operational execution of clinical trials in metabolic diseases, with a focus on diabetes, obesity and related cardiorenal indications. Based in Essen (NRW), Germany, we combine clinical expertise with structured processes to deliver studies reliably in complex therapeutic settings.

Our work covers the key building blocks of efficient study conduct: patient recruitment, study execution and site management. We support trial teams with clear routines, consistent documentation and an implementation approach aligned with sponsor and CRO requirements across the trial lifecycle.

Metabolic indications continue to see sustained R&D activity, including a growing number of programmes in obesity-related drug development. In this environment, dependable recruitment and execution are relevant for timelines and data quality. We contribute through practical site operations and predictable study workflows.